Pre-pregnancy care and pregnancy outcomes in type 1 diabetes mellitus: a comparison of continuous subcutaneous insulin infusion and multiple daily injection therapy
Pre-pregnancy care improves pregnancy outcomes in type 1 diabetes mellitus (T1DM). Continuous subcutaneous insulin infusion (CSII) therapy and multiple daily injection (MDI) therapy can both be used to achieve glycaemic targets, but few data are available to compare their efficacy in pre-pregnancy care.
To compare MDI and CSII in pre-pregnancy care in T1DM.
Retrospective database review of women with T1DM attending the Dublin Diabetes in Pregnancy Centre.
464 women with T1DM (40 treated with CSII) were included. Women attending for pre-pregnancy care had lower HbA1c levels at booking to antenatal services [52 ± 10 mmol/mol (6.9 ± 0.9 %) vs. 62 ± 16 mmol/mol (7.8 ± 1.5 %), p < 0.001], and booked at an earlier gestation (6 ± 2 vs. 8 ± 6 weeks, p < 0.001). In those who attended for pre-pregnancy care, the CSII group had lower HbA1c levels at booking than those using MDI [48 ± 8 mmol/mol (6.5 ± 0.7 %) vs. 53 ± 10 mmol/mol (7.0 ± 0.9 %), p = 0.03]. Gestational age at delivery and birth weight did not differ between groups. Caesarean section rates were associated with CSII use (p < 0.001), duration of diabetes (p = 0.002), and parity (p = 0.006). Nulliparous women using CSII with a longer history of diabetes were more likely to deliver by Caesarean section. There was no perinatal mortality.
Pre-pregnancy care delivered by a specialist multi-disciplinary team effectively reduces HbA1c levels peri-conception. CSII use results in lower HbA1c levels in pre-pregnancy care in selected individuals and should be considered in women with T1DM planning pregnancy.
KeywordsDiabetes Pregnancy Pre-pregnancy planning Insulin infusion
The authors would like to acknowledge the Eithne Coleman, Laura O’Shea and Ailbhe McCarthy who contributed to the care of the women in this study, and who also aided in data collection. This clinical research project did not receive any specific funding.
Conflict of interest
The authors have no conflicts of interest to disclose. No competing financial interests exist.
- 6.National Institute for Health and Clinical Excellence. Diabetes in pregnancy: management of diabetes and its complications from pre-conception to the postnatal period. London: NICE, 2008. http://www.nice.org.uk/CG063
- 11.Chen R, Ben-Haroush A, Weismann-Brenner A, Melamed N, Hod M, Yogev Y (2007) Level of glycaemic control and pregnancy outcome in type 1 diabetes: a comparison between multiple daily injections and continuous subcutaneous insulin infusions. Am J Obstet Gynecol 197(4):404.e1–404.e5CrossRefGoogle Scholar
- 12.Cummins E, Royle P, Snaith A et al (2010) Clinical effectiveness and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes: systematic review and economic evaluation. Health Technol Assess 14(11):iii–iv, xi–xvi, 1–181Google Scholar
- 17.Sibai BM, Caritis SN, Hauth JC et al (2000) Preterm delivery in women with pregestational diabetes mellitus or chronic hypertension relative to women with uncomplicated pregnancies. The National institute of Child health and Human Development Maternal- Fetal Medicine Units Network. Am J Obstet Gynecol 183(6):1520–1524PubMedCrossRefGoogle Scholar